🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John de Groot

Henry Ford Health System

ORCID: 0000-0003-1454-6461

Also affiliated with University of California, San Francisco

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168
Top 100%
0DataRank
Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Papers

Driven by 22 papers — median percentile 0. Top paper: “Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine”.

Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine

Nature Communications(2021)10.1038/s41467-021-24240-3
N/A
2.2DataRank · unranked
55 citations

Jeffrey J. Ackroyd, Victoria C. Yan, Sunada Khadka, Lin Wang, Ko‐Chien Chen +16 more

A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma

CNS Oncology(2022)10.2217/cns-2022-0005
N/A
1.7DataRank · unranked
77 citations

Martina Ott, Jun Wei, Cynthia Kassab, Dexing Fang, Hinda Najem +15 more

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2500
N/A
0.835DataRank · unranked
261 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0131
N/A
0.757DataRank · unranked
155 citations

Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota +79 more

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Nature Medicine(2023)10.1038/s41591-023-02464-8
N/A
0.604DataRank · unranked
55 citations

Kelly Hotchkiss, Ian F. Parney, John de Groot, Solmaz Sahebjam, Nader Sanai +31 more

Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1

Acta Neuropathologica(2022)10.1007/s00401-022-02478-5
N/A
0.598DataRank · unranked
53 citations

Emily A. Sloan, Rohit Gupta, Jasper Wu, Drew Pratt, Harish N. Vasudevan +37 more

Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival

Neuro-Oncology(2023)10.1093/neuonc/noad002
N/A
0.578DataRank · unranked
46 citations

Patrick Y. Wen, Susan M. Chang, Martin J. van den Bent, Michael A. Vogelbaum, Gang Li +11 more

A Neuroradiologist’s Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults

American Journal of Neuroradiology(2024)10.3174/ajnr.a8396
N/A
0.533DataRank · unranked
34 citations

Francesco Sanvito, Timothy F. Cloughesy, Raymond Y. Huang, Javier Villanueva-Meyer, Whitney B. Pope +21 more

Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses

Neuro-Oncology(2024)10.1093/neuonc/noae214
N/A
0.494DataRank · unranked
26 citations

Nadeem Al-Adli, Jacob S. Young, Rohit Gupta, Ramin A. Morshed, Jasper Wu +24 more

Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference

The Lancet Oncology(2023)10.1016/s1470-2045(23)00005-0
N/A
0.494DataRank · unranked
26 citations

Mei‐Yin C. Polley, Laura Alder, Priscilla K. Brastianos, Carey K. Anders, Hussein A. Tawbi +9 more

A brave new framework for glioma drug development

The Lancet Oncology(2024)10.1016/s1470-2045(24)00190-6
N/A
0.494DataRank · unranked
26 citations

Philipp Karschnia, Karisa C. Schreck, Marjolein Geurts, Timothy F. Cloughesy, Jason T. Huse +34 more

A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa146
N/A
0.457DataRank · unranked
20 citations

Tiffany R. Hodges, Nazanin Majd, Kristin Alfaro-Munoz, Wajd N. Al‐Holou, Dima Suki +15 more

Chimeric antigen receptor T-cell therapy in patients with malignant glioma—From neuroimmunology to clinical trial design considerations

Neuro-Oncology(2024)10.1093/neuonc/noae203
N/A
0.373DataRank · unranked
11 citations

Jacob S. Young, Sarah Cook Quackenbush, Mustafa Khasraw, John de Groot, Hideho Okada +1 more

Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac129
N/A
0.165DataRank · unranked
2 citations

Swapnil Khose, Halyna Pokhylevych, Arnold C. Paulino, Mary Frances McAleer, Amol J. Ghia +20 more

Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy

Neuro-Oncology(2025)10.1093/neuonc/noaf055
N/A
0DataRank · unranked
18 citations

Christopher Zou, A L Hubbard, Sasha Sengelmann, Laine Goudy, I‐Ching Wang +14 more

Robust detection of oncometabolic aberrations by 1H–13C heteronuclear single quantum correlation in intact biological specimens

Communications Biology(2020)10.1038/s42003-020-1055-5
N/A
0DataRank · unranked
5 citations

Victoria C. Yan, Kenisha Arthur, Jeffrey J. Ackroyd, Sunada Khadka, John de Groot +3 more

The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma

Cancers(2023)10.3390/cancers15143739
N/A
0DataRank · unranked
19 citations

Shashwat Tripathi, Corey Dussold, Hinda Najem, John de Groot, Rimas V. Lukas +2 more

Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastoma

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad132
N/A
0DataRank · unranked
8 citations

Emmanuel Martínez-Ledesma, Jian‐Wen Dong, Rajasekaran Mahalingam, Soon Young Park, Yuji Piao +5 more

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad032
N/A
0DataRank · unranked
12 citations

Max Mastall, Heather Lin, Kenneth R. Hess, Ying Yuan, Manuela Martín-Bejarano García +21 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168
Top 100%
0DataRank
Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168.v1
Top 100%
0DataRank
Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives

Cells(2024)10.3390/cells13090726
N/A
0DataRank · unranked
35 citations

Marco Gallus, Su Phyu, Jeffrey Haegelin, John de Groot, Hideho Okada +1 more